Scholars Central

Review articlePublished 2019

The Use of Carboranes in Cancer Drug Development

Authors: Emilia Ohsone-Zargham Mason, Christian A Mason, Mark W Lee Jr

Medicinal Chemistry

Volume 9 · Issue 4 · Pages 44–55

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Over the past decade, there has been a rising interest in the use of carboranes as a potential pharmacophoric moiety in the development of new drugs for the treatment of various types of cancer. The unique physical and chemical properties of carboranes make their use attractive in drug development. In several instances, the inclusion of carboranes into a drug structure has increased the agent’s binding affinity, potency, or bioavailability. The purpose of this review is to highlight applications of carboranes to the medicinal chemistry of cancer.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Medicinal Chemistry.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMedicinal Chemistry
  • SubjectChemistry
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Emilia Ohsone-Zargham Mason”
  • BylineArticles whose byline prints “Christian A Mason”
  • BylineArticles whose byline prints “Mark W Lee Jr”